Research Background: Atopic dermatitis (AD) is a chronic inflammatory skin condition in children that significantly impacts physical health and quality of life. Adherence to treatment regimens is crucial for effective disease management but is often hindered by various psychosocial and socioeconomic barriers. Parental mental health issues, family dynamics, financial constraints, and limited access to specialized care contribute to inconsistent treatment adherence, exacerbating the condition. Purpose/Aim: The aim of this study is to explore the multifaceted barriers to treatment adherence in children with AD and evaluate the effectiveness of current interventions targeting these challenges. The study seeks to identify strategies that can improve adherence and health outcomes by addressing psychosocial and socioeconomic factors. Method: The method involves a comprehensive review of existing literature on the impact of psychosocial and socioeconomic factors on treatment adherence in children with AD. The study also examines various interventions designed to address these barriers, including community support programs, family-centered interventions, financial aid, integrated care models, and telehealth solutions. Results: Results indicate that psychosocial barriers, such as parental anxiety and depression, significantly hinder effective disease management. Family dynamics, including poor communication and single-parent households, complicate adherence efforts. Socioeconomic factors, such as financial constraints and limited healthcare access, further impede adherence. Interventions that address these barriers show promise in improving treatment adherence and health outcomes. Community support programs and family-centered interventions enhance parental mental health and family communication. Financial aid programs and integrated care models help mitigate economic and logistical challenges. Telehealth solutions improve access to specialized care, particularly in underserved areas. Conclusion: The study concludes that a holistic approach integrating medical treatment with psychosocial and socioeconomic support is essential for managing pediatric AD effectively. Policy recommendations include increased funding for community support programs, expanded telehealth services, and the integration of social services with medical care. Addressing these barriers comprehensively can enhance treatment adherence and improve the quality of life for children with AD. Further research should focus on long-term outcomes and diverse
References
[1]
Langan, S.M., Mulick, A.R., Rutter, C.E., Silverwood, R.J., Asher, I., García‐Marcos, L., et al. (2023) Trends in Eczema Prevalence in Children and Adolescents: A Global Asthma Network Phase I Study. Clinical & Experimental Allergy, 53, 337-352. https://doi.org/10.1111/cea.14276
[2]
Ali, F., Vyas, J. and Finlay, A. (2020) Counting the Burden: Atopic Dermatitis and Health-Related Quality of Life. Acta DermatoVenereologica, 100, 330-340. https://doi.org/10.2340/00015555-3511
[3]
Yang, L., Fu, J. and Zhou, Y. (2020) Research Progress in Atopic March. Frontiers in Immunology, 11, Article 1907. https://doi.org/10.3389/fimmu.2020.01907
[4]
Tsakok, T., Marrs, T., Mohsin, M., Baron, S., du Toit, G., Till, S., et al. (2016) Does Atopic Dermatitis Cause Food Allergy? a Systematic Review. Journal of Allergy and Clinical Immunology, 137, 1071-1078. https://doi.org/10.1016/j.jaci.2015.10.049
[5]
Sandhu, J.K., Wu, K.K., Bui, T. and Armstrong, A.W. (2019) Association between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-Analysis. JAMA Dermatology, 155, 178-187. https://doi.org/10.1001/jamadermatol.2018.4566
[6]
McCleary, K. (2020). Understanding the Lived Experience of EC-Zema. More Than Skin Deep. http://www.morethanskindeep-eczema.org/uploads/1/2/5/3/125377765/mtsd_report_-_digital_file.pdf
[7]
Chovatiya, R., Begolka, W.S., Thibau, I.J. and Silverberg, J.I. (2021) Impact and Associations of Atopic Dermatitis Out-Of-Pocket Health Care Expenses in the United States. Dermatitis, 33, S43-S51. https://doi.org/10.1097/der.0000000000000795
[8]
Smith Begolka, W., Chovatiya, R., Thibau, I.J. and Silverberg, J.I. (2020) Financial Burden of Atopic Dermatitis Out-Of-Pocket Health Care Expenses in the United States. Dermatitis, 32, S62-S70. https://doi.org/10.1097/der.0000000000000715
[9]
Kelly, K.A., Balogh, E.A., Kaplan, S.G. and Feldman, S.R. (2021) Skin Disease in Children: Effects on Quality of Life, Stigmatization, Bullying, and Suicide Risk in Pediatric Acne, Atopic Dermatitis, and Psoriasis Patients. Children, 8, Article 1057. https://doi.org/10.3390/children8111057
[10]
Na, C.H., Chung, J. and Simpson, E.L. (2019) Quality of Life and Disease Impact of Atopic Dermatitis and Psoriasis on Children and Their Families. Children, 6, Article 133. https://doi.org/10.3390/children6120133
[11]
McKenzie, C. and Silverberg, J.I. (2018) Association of Family Structure with Atopic Dermatitis in US Children. Journal of the American Academy of Dermatology, 79, 638-644.e4. https://doi.org/10.1016/j.jaad.2018.05.039
[12]
Yang, E.J., Beck, K.M., Sekhon, S., Bhutani, T. and Koo, J. (2018) The Impact of Pediatric Atopic Dermatitis on Families: A Review. Pediatric Dermatology, 36, 66-71. https://doi.org/10.1111/pde.13727
[13]
Weingarten, S.R. (2002) Interventions Used in Disease Management Programmes for Patients with Chronic Illness—Which Ones Work? Meta-Analysis of Published Reports. BMJ, 325, 925-925. https://doi.org/10.1136/bmj.325.7370.925
[14]
Leeman, E.J. and Loman, L. (2024) Health Literacy in Adult Patients with Atopic Dermatitis: A Cross-Sectional Study. Journal of Allergy and Clinical Immunology: Global, 3, Article ID: 100218. https://doi.org/10.1016/j.jacig.2024.100218
[15]
Pan, J., Yu, H., Hu, B. and Li, Q. (2022) Urban-Rural Difference in Treatment Adherence of Chinese Hypertensive Patients. Patient Preference and Adherence, 16, 2125-2133. https://doi.org/10.2147/ppa.s377203
[16]
Glazer, A.M. and Rigel, D.S. (2017) Analysis of Trends in Geographic Distribution of US Dermatology Workforce Density. JAMA Dermatology, 153, 472-473. https://doi.org/10.1001/jamadermatol.2016.6032
[17]
Storm, A., Andersen, S.E., Benfeldt, E. and Serup, J. (2008) One in 3 Prescriptions Are Never Redeemed: Primary Nonadherence in an Outpatient Clinic. Journal of the American Academy of Dermatology, 59, 27-33. https://doi.org/10.1016/j.jaad.2008.03.045
[18]
Krejci-Manwaring, J., Tusa, M.G., Carroll, C., Camacho, F., Kaur, M., Carr, D., et al. (2007) Stealth Monitoring of Adherence to Topical Medication: Adherence Is Very Poor in Children with Atopic Dermatitis. Journal of the American Academy of Dermatology, 56, 211-216. https://doi.org/10.1016/j.jaad.2006.05.073
[19]
Hix, E., Gustafson, C.J., O’Neill, J.L., Huang, K., Sandoval, L.F., Harrison, J., et al. (2013) Adherence to a Five Day Treatment Course of Topical Fluocinonide 0.1% Cream in Atopic Dermatitis. Dermatology Online Journal, 19, Article ID: 20029. https://doi.org/10.5070/d31910020029
[20]
Carroll, C.L., Balkrishnan, R., Feldman, S.R., Fleischer, A.B. and Manuel, J.C. (2005) The Burden of Atopic Dermatitis: Impact on the Patient, Family, and Society. Pediatric Dermatology, 22, 192-199. https://doi.org/10.1111/j.1525-1470.2005.22303.x
[21]
Mancini, A.J., Kaulback, K. and Chamlin, S.L. (2008) The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review. Pediatric Dermatology, 25, 1-6. https://doi.org/10.1111/j.1525-1470.2007.00572.x
[22]
Richards, H., Fortune, D. and Griffiths, C. (2006) Adherence to Treatment in Patients with Psoriasis. Journal of the European Academy of Dermatology and Venereology, 20, 370-379. https://doi.org/10.1111/j.1468-3083.2006.01565.x
[23]
Loiselle, A.R., Chovatiya, R., Thibau, I.J., Johnson, J.K., Guadalupe, M. and Smith Begolka, W. (2024) Evaluating Access to Prescription Medications in the Atopic Dermatitis Patient Population in the USA. Dermatology and Therapy, 14, 1811-1821. https://doi.org/10.1007/s13555-024-01205-0
[24]
Sidbury, R., Tom, W.L., Bergman, J.N., Cooper, K.D., Silverman, R.A., Berger, T.G., et al. (2014) Guidelines of Care for the Management of Atopic Dermatitis: Section 4. Prevention of Disease Flares and Use of Adjunctive Therapies and Approaches. Journal of the American Academy of Dermatology, 71, 1218-1233. https://doi.org/10.1016/j.jaad.2014.08.038
[25]
Lawton, S., Roberts, A. and Gibb, C. (2005) Supporting the Parents of Children with Atopic Eczema. British Journal of Nursing, 14, 693-696. https://doi.org/10.12968/bjon.2005.14.13.18446
[26]
Senra, M.S. and Wollenberg, A. (2014) Psychodermatological Aspects of Atopic Dermatitis. British Journal of Dermatology, 170, 38-43. https://doi.org/10.1111/bjd.13084
[27]
Wan, J., Takeshita, J., Shin, D.B. and Gelfand, J.M. (2020) Mental Health Impairment among Children with Atopic Dermatitis: A United States Population-Based Cross-Sectional Study of the 2013-2017 National Health Interview Survey. Journal of the American Academy of Dermatology, 82, 1368-1375. https://doi.org/10.1016/j.jaad.2019.10.019
[28]
Reimer‐Taschenbrecker, A., Daniel, M., Rangel, S.M. and Paller, A.S. (2023) Do Socioeconomic Factors Impact Atopic Dermatitis Outcome? A Single‐Center Study. Pediatric Dermatology, 40, 1049-1056. https://doi.org/10.1111/pde.15455
[29]
Chung, J. and Simpson, E.L. (2019) The Socioeconomics of Atopic Dermatitis. Annals of Allergy, Asthma & Immunology, 122, 360-366. https://doi.org/10.1016/j.anai.2018.12.017
[30]
Patrick, G., Mattia, A., Melchor, J., Leonard, M., Quirindongo, E., Sangha, N., et al. (2024) Systematic Review of Existing Literature Regarding the Prevalence of Pediatric Atopic Dermatitis in Honduras. JAAD International, 15, 44-50. https://doi.org/10.1016/j.jdin.2023.12.009
[31]
Al-Dhahir, I., Reijnders, T., Faber, J.S., van den Berg-Emons, R.J., Janssen, V., Kraaijenhagen, R., et al. (2021) Barriers and Facilitators in eHealth-Based Lifestyle Intervention Programs for People with Lower Socioeconomic Status: A Scoping Review (Preprint). Journal of Medical Internet Research, 24, e34229. https://doi.org/10.2196/34229
[32]
Armstrong, A.W., Johnson, M.A., Lin, S., Maverakis, E., Fazel, N. and Liu, F. (2015) Patient-Centered, Direct-Access Online Care for Management of Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatology, 151, 154-160. https://doi.org/10.1001/jamadermatol.2014.2299
[33]
Whited, J.D. (2006) Teledermatology Research Review. International Journal of Dermatology, 45, 220-229. https://doi.org/10.1111/j.1365-4632.2004.02427.x
[34]
Eminović, N., de Keizer, N.F., Bindels, P.J.E. and Hasman, A. (2007) Maturity of Teledermatology Evaluation Research: A Systematic Literature Review. British Journal of Dermatology, 156, 412-419. https://doi.org/10.1111/j.1365-2133.2006.07627.x
[35]
Froehlich, W., Seitaboth, S., Chanpheaktra, N. and Pugatch, D. (2009) Case Report: An Example of International Telemedicine Success. Journal of Telemedicine and Telecare, 15, 208-210. https://doi.org/10.1258/jtt.2008.081001
[36]
Bass, A., Anderson, K. and Feldman, S. (2015) Interventions to Increase Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review. Journal of Clinical Medicine, 4, 231-242. https://doi.org/10.3390/jcm4020231
[37]
Ersser, S.J., Cowdell, F., Latter, S., Gardiner, E., Flohr, C., Thompson, A.R., et al. (2014) Psychological and Educational Interventions for Atopic Eczema in Children. Cochrane Database of Systematic Reviews, 2017, CD004054. https://doi.org/10.1002/14651858.cd004054.pub3
[38]
Sokel, B., Christie, D., Kent, A., Lansdown, R., et al. (1993) A Comparison of Hypnotherapy and Biofeedback in the Treatment of Childhood Atopic Eczema. Contemporary Hypnosis, 10, 145-154.
[39]
Mostafa, N. and Smith, S. (2023) Improving Psychological Health Outcomes in Children with Atopic Dermatitis. Clinical, Cosmetic and Investigational Dermatology, 16, 2821-2827. https://doi.org/10.2147/ccid.s393254
[40]
Rork, J.F. (2012) Parental Response to Written Eczema Action Plans in Children with Eczema. Archives of Dermatology, 148, 391-392. https://doi.org/10.1001/archdermatol.2011.2267
[41]
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., et al. (2014) Interventions for Enhancing Medication Adherence. Cochrane Database of Systematic Reviews, 2014, CD000011. https://doi.org/10.1002/14651858.cd000011.pub4
[42]
Koster, E.S., Philbert, D., de Vries, T.W., van Dijk, L. and Bouvy, M.L. (2015) “IJustForgettoTakeIt”: Asthma Self-Management Needs and Preferences in Adolescents. Journal of Asthma, 52, 831-837. https://doi.org/10.3109/02770903.2015.1020388
[43]
Faught, J., Bierl, C., Barton, B. and Kemp, A. (2007) Stress in Mothers of Young Children with Eczema. Archives of Disease in Childhood, 92, 683-686. https://doi.org/10.1136/adc.2006.112268
